Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Total Current Liabilities (2023 - 2026)

Updated

Translational Development Acquisition (TDACU) posted Total Current Liabilities of $1.75 million for Q2 2026, up 515.3% from $284,682 a year earlier and up 103.4% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Total Current Liabilities (2023 - 2026) Analysis & Trends

At the end of FY2025, Translational Development Acquisition's Total Current Liabilities came in at $544,073, up 158.7% from FY2024.

  • In prior years, Translational Development Acquisition's Total Current Liabilities was $210,303 in FY2024 (-58.7%) and $509,679 in FY2023.
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q4 2023.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last three quarters, with growth averaging 195.5% over the last four quarters.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $861,085 (Q1 2026), $544,073 (Q4 2025) and $422,845 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.75 Mn
Mar 31, 2026 861,085.00
Dec 31, 2025 544,073.00
Sep 30, 2025 422,845.00
Jun 30, 2025 284,682.00
Mar 31, 2025 322,900.00
Dec 31, 2024 210,303.00
Dec 31, 2023 509,679.00
API Access

Translational Development Acquisition Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=TDACU&period=max&api_key=YOUR_API_KEY